Open Search Promised For New NIH Director

WASHINGTON-The search for a successor to James Wyngaarden as director of the National Institutes of Health has begun, and members of the committee given the job of sifting through the applications say that the process isn't wired. "There's no shoo-in for the job," says Joseph ("Ed") Rall, NIH deputy director for intramural research. "I expect an open and honest search. I don't see anyone on the committee with a political agenda." James Mason, the new assistant secretary for health within the Dep

Written byJeffrey Mervis
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

"There's no shoo-in for the job," says Joseph ("Ed") Rall, NIH deputy director for intramural research. "I expect an open and honest search. I don't see anyone on the committee with a political agenda."

James Mason, the new assistant secretary for health within the Department of Health and Human Services (HHS), is chairman of a nine-member advisory committee that will handle the search. The committee consists of Rall: microbiologist Harold Amos of Harvard University; Theodore Cooper, chief executive officer of the Upjohn Company and the assistant secretary for health under President Ford; Assistant Surgeon General James Dickson; James Gavin, professor of medicine at the University of Oklahoma health sciences center; Nobel laureate Frederick Robbins of Case Western Reserve University; Richard Ross, dean of the Johns Hopkins University medical school; and Virginia Weldon, vice president for scientific affairs at Monsanto Company.

The panel, which met for the first time earlier this ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies